Ellevest Inc’s Applied Therapeutics APLT Stock Holding History

Ellevest Inc’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-48	Closed	-$1K	–	1383
2021 Q2	$1K	Buy	+48	New	+$909	﹤0.01%	1112

Other funds holding APLT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Ellevest Inc's APLT Position: Q3 2021 in Review

Ellevest Inc sold out of Applied Therapeutics (APLT) in Q3 2021, closing a stake of 48 shares — an estimated $1K sold.

Ellevest Inc first reported a position in APLT in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 70 funds tracked by Wall St. Rank hold APLT as of Q3 2021.

Ellevest Inc reported no remaining Applied Therapeutics position as of Q3 2021 after selling out during the quarter.
Ellevest Inc sold 48 Applied Therapeutics shares in Q3 2021, an estimated $1K.
Ellevest Inc first reported a position in Applied Therapeutics in Q2 2021 and held it in 1 quarter.
Ellevest Inc's Applied Therapeutics position peaked at $1K in Q2 2021.
70 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2021.

Based on Ellevest Inc's 13F filing for Q3 2021, filed 19 Oct 2021.